Organization · Accelerator
Altitude Lab
Altitude Lab is a life science accelerator based in Salt Lake City, Utah, focused on launching innovative startups in the bio and healthcare sectors. The organization aims to create 100 market-defining startups by 2035.
Overview
What Altitude Lab does
What Altitude Lab is
Altitude Lab is a life science accelerator based in Salt Lake City, Utah, focused on launching innovative startups in the bio and healthcare sectors. The organization aims to create 100 market-defining startups by 2035.
How it participates in the startup ecosystem
The current public profile supports funder and program host and event host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Accelerator
- Founded
- Founded in 2020
- Approximate age
- About 6 years
- Structured capabilities
- Funder · Program host · Event host
- Last reviewed
- March 27, 2026
What Accelerator means
An accelerator is a structured, short-term program designed to speed up a startup's progress toward product-market fit, traction, fundraising, or scale.
Open the glossary entryOfficial channels
Find Altitude Lab elsewhere
Open the official website or a supported primary organization account.
Capability profile
Altitude Lab as a funder
Investment thesis
Altitude Lab is dedicated to launching 100 market-defining startups by 2035, focusing on enabling field-defining bio startups and building a talent and technology engine for the regions it serves.
Focus narrative
Altitude Lab primarily invests in early-stage life science and healthcare companies. The organization emphasizes platform technology development over traditional therapeutic target validation. Key areas of interest include TechBio, autonomous lab and science agents, biomanufacturing, and high-content data generation platforms.
Value beyond capital
Altitude Lab provides a two-year acceleration program that includes non-dilutive grants, stipends, lab space for first-time academic founders, and pre-seed investments ranging from $100,000 to $250,000.
Terms and economics
- Typical check
- $100,000–$250,000
Focus and fit
- Stages
- Accelerator · Pre-seed
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 9
Portfolio context
Notable portfolio companies include: 3Helix: Engineering platform collagen technology for diagnosing fibrosis and advancing tissue regeneration. Anziva Pharmaceuticals: Innovating drug formulations for improved patient treatments. Aumenta Biosciences: Discovering immunotherapies inspired by the microbiome. Bioparin: Developing bioengineered heparin using genetically engineered microbes. Bonneville Bio: Focused on novel therapeutics for cancer treatment. CaLycia Biosciences: Developing engineered myeloid cell therapies for solid tumors. Caelium: Creating a brain-penetrant microtubule stabilizer for neurodegenerative diseases. Conduit Bio: Improving drug discovery success rates through digital cell technology. DigiBeat Health Monitoring Systems: Simplifying cardiac screening for medical assistance and home patients.
Capability profile
Altitude Lab as a program host
Program thesis
Altitude Lab is committed to launching 100 market-defining startups by 2035, focusing on enabling field-defining bio startups and building a talent and technology engine for the regions it serves.
Focus narrative
Altitude Lab primarily invests in early-stage life science and healthcare companies. The organization emphasizes platform technology development over traditional therapeutic target validation. Key areas of interest include TechBio, autonomous lab and science agents, biomanufacturing, and high-content data generation platforms.
Value and support
Altitude Lab offers a two-year acceleration program that includes a non-dilutive grant covering one year of residency and coaching, a stipend and lab space for first-time academic founders, and pre-seed investments ranging from $100,000 to $250,000.
Terms and economics
- Indicative investment
- $100,000
Format and cadence
- Typical duration
- 104 weeks
Availability
- Application state
- Not published
Focus and fit
- Stages
- Accelerator · Pre-seed
- Regions
- United States
Alumni and track record
Alumni context
Notable portfolio companies include 3Helix, Anziva Pharmaceuticals, Aumenta Biosciences, Bioparin, Bonneville Bio, CaLycia Biosciences, Caelium, Conduit Bio, and DigiBeat Health Monitoring Systems.
Capability profile
Altitude Lab as an event host
Event focus
Altitude Lab is dedicated to launching 100 market-defining startups by 2035, focusing on enabling field-defining bio startups and building a talent and technology engine for the regions it serves. The accelerator primarily invests in early-stage life science and healthcare companies, emphasizing platform technology development over traditional therapeutic target validation.
Format narrative
Altitude Lab offers a two-year acceleration program that includes various grants and funding opportunities, along with coaching and residency support for startups.
Participant value
Altitude Lab provides startups with essential resources, funding, and mentorship to navigate the complexities of the life sciences sector, ultimately aiming to enhance their chances of success in the market.
Format and cadence
- Event types
- demo-day and summit
- Modality
- in-person
- Startups can present
- Yes
Availability
- Registration state
- Not currently accepting
- Next recorded event
- April 15, 2026
- Next event location
- The Gallivan Center, Salt Lake City
Audience and fit
- Stages
- Pre-seed · Seed
- Audience
- Founders · Investors
- Regions
- United States
Common questions
What to know about Altitude Lab
Upseed classifies Altitude Lab under the Accelerator organization type. Its current public profile includes funder, program host, and event host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.